{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T14:33:57Z","timestamp":1695134037421},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/mcg.0b013e318184a470","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T12:38:17Z","timestamp":1242909497000},"page":"470-476","source":"Crossref","is-referenced-by-count":7,"title":["Thyroid Disorders and Occurrence of Nonorgan-specific Autoantibodies (NOSA) in Patients With Chronic Hepatitis C Before and During Antiviral Induction Therapy With Consensus Interferon (Interferon Alfacon-1)"],"prefix":"10.1097","volume":"43","author":[{"given":"Holger G.","family":"Hass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhild","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Nehls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210305","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/jhep.2001.26371","article-title":"Hepatitis Interventional Therapy Group. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C","volume":"34","author":"Lindsay","year":"2001","journal-title":"Hepatology"},{"key":"R2-15-20210305","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM200012073432301","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C","volume":"343","author":"Zeuzem","year":"2000","journal-title":"N Engl J Med"},{"key":"R3-15-20210305","first-page":"1925","article-title":"Long-term outcome of interferon-\u03b1-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment","volume":"86","author":"Carella","year":"2001","journal-title":"J Clin Endo Metabol"},{"key":"R4-15-20210305","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2265.2002.01553.x","article-title":"Thyreotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis","volume":"56","author":"Wong","year":"2002","journal-title":"Clin Endocrinol"},{"key":"R5-15-20210305","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/PL00011206","article-title":"Rheumatoid arthritis induced by alpha-interferon therapy","volume":"20","author":"Passos de Souza","year":"2001","journal-title":"Clin Rheumatol"},{"key":"R6-15-20210305","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.48.3.378","article-title":"Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C","volume":"48","author":"Wesche","year":"2001","journal-title":"Gut"},{"key":"R7-15-20210305","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(00)02880-4","article-title":"Onset of coeliac disease during treatment with interferon for chronic hepatitis C","volume":"356","author":"Cammarota","year":"2000","journal-title":"Lancet"},{"key":"R8-15-20210305","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0889-857X(05)70013-2","article-title":"Hepatitis C-associated autoimmune disorders","volume":"24","author":"McMurray","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"R9-15-20210305","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2004.01.008","article-title":"Interferon alpha\u2013a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity","volume":"111","author":"Eisenbart","year":"2004","journal-title":"Clin Immunol"},{"key":"R10-15-20210305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/jaut.1999.0360","article-title":"Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study","volume":"14","author":"Ganne-Carrie","year":"2000","journal-title":"J Autoimmun"},{"key":"R11-15-20210305","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/jir.1996.16.489","article-title":"The biologic activity and molecular cha-racterization of a novel synthetic interferon-alpha species, consensus interferon","volume":"16","author":"Blatt","year":"1996","journal-title":"J Interferon Cytokine Res"},{"key":"R14-15-20210305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jhep.2005.10.021","article-title":"Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study","volume":"44","author":"Cornberg","year":"2006","journal-title":"J Hepatol"},{"key":"R15-15-20210305","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hep.1840180205","article-title":"High prevalence of thyroid autoantibodies in a prospective ceries of patients with chronic hepatitis C before interferon therapy","volume":"18","author":"Tran","year":"1993","journal-title":"Hepatology"},{"key":"R16-15-20210305","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.1996.751768.x","article-title":"Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy","volume":"44","author":"Marazuela","year":"1996","journal-title":"Clin Endocrinol"},{"key":"R17-15-20210305","first-page":"2978","article-title":"Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection","volume":"96","author":"Peo\u0107h","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R18-15-20210305","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archinte.158.13.1445","article-title":"Increased risk of autoimmune thyroid disease in hepatitis C vs. hepatitis B before, during, and after discontinuing interferon therapy","volume":"158","author":"Fernandez-Soto","year":"1998","journal-title":"Arch Intern Med"},{"key":"R19-15-20210305","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jc.2004-0627","article-title":"Interferon-\u03b1-related thyroid disease: pathophysiological, epidemiological, and clinical aspects","volume":"89","author":"Carella","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-15-20210305","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/105072503768499680","article-title":"The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area","volume":"13","author":"Volzke","year":"2003","journal-title":"Thyroid"},{"key":"R21-15-20210305","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF03044819","article-title":"Prevalence of thyroid gland dysfunctions in 50 to 80-year-old patients. An epidemiologic cross-sectional study in a southwestern community","volume":"92","author":"Seck","year":"1997","journal-title":"Med Klin"},{"key":"R22-15-20210305","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/hep.510260127","article-title":"Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alpha therapy","volume":"26","author":"Deutsch","year":"1997","journal-title":"Hepatology"},{"key":"R23-15-20210305","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/0016-5085(92)90348-3","article-title":"Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha","volume":"102","author":"Lisker-Melman","year":"1992","journal-title":"Gastroenterology"},{"key":"R24-15-20210305","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03345087","article-title":"Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study","volume":"25","author":"Mazziotti","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"R25-15-20210305","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.20816","article-title":"LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?","volume":"42","author":"Marceau","year":"2005","journal-title":"Hepatology"},{"key":"R26-15-20210305","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3748\/wjg.v11.i4.482","article-title":"Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study","volume":"11","author":"Gatselis","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R27-15-20210305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2334-4-4","article-title":"The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C","volume":"4","author":"Wasmuth","year":"2004","journal-title":"BMC Infect Dis"},{"key":"R28-15-20210305","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/00365529609009156","article-title":"Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy","volume":"31","author":"Noda","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"R29-15-20210305","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/gut.49.4.596a","article-title":"Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C","volume":"49","author":"Wesche","year":"2001","journal-title":"Gut"},{"key":"R30-15-20210305","first-page":"1125","article-title":"Auto-immunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection","volume":"23","author":"Betterle","year":"2001","journal-title":"Diabetes Care"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-200905000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:21:58Z","timestamp":1618035718000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-200905000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e318184a470","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}